Proteasome activity assay

MR Mark J. Ranek
CO Christian Oeing
RS Rebekah Sanchez-Hodge
KK Kristen M. Kokkonen-Simon
DD Danielle Dillard
MA M. Imran Aslam
PR Peter P. Rainer
SM Sumita Mishra
BD Brittany Dunkerly-Eyring
RH Ronald J. Holewinski
CV Cornelia Virus
HZ Huaqun Zhang
MM Matthew M. Mannion
VA Vineet Agrawal
VH Virginia Hahn
DL Dong I. Lee
MS Masayuki Sasaki
JE Jennifer E. Van Eyk
MW Monte S. Willis
RP Richard C. Page
JS Jonathan C. Schisler
DK David A. Kass
request Request a Protocol
ask Ask a question
Favorite

Snap-frozen tissues and cultured NRCMs were homogenized on ice in cytosolic extraction buffer (50 mM Tris-HCl pH 7.5, 250 mM Sucrose, 5 mM MgCl2, 0.5 mM EDTA, and 1 mM DTT). Protein concentrations were determined with bicinchoninic acid (BCA) reagents (Pierce) and equally concentrated in proteasome assay buffer (50 mM Tris-HCl pH 7.5, 40 mM KCl, 5 mM MgCl2, and 1 mM DTT). Chymotrypsin-like, trypsin-like, and caspase-like activities were determined in the presence of 28 μM (chymotrypsin) or 14 μM (trypsin and caspase) ATP, utilizing the following fluorogenic substrates: Suc-LLVY-AMC (18 μM, Boston Biochem #S280), Ac-RLR-AMC (45 μM, Boston Biochem #S290), and Z-Leu-Leu-Glu-AMC (40 μM, Boston Biochem #S230), respectively. The plate was read at an excitation wavelength of 380 nm and an emission wavelength of 460 nm using a Spectramax M5 (Molecular Devices). Activity was combined, using a 50:25:25 ratio for relative contribution of chymotrypsin, trypsin, and caspase-like activities49.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A